160 related articles for article (PubMed ID: 30632564)
1. Boronate-crosslinked polysaccharide conjugates for pH-responsive and targeted drug delivery.
Zhang YH; Zhang YM; Yu J; Wang J; Liu Y
Chem Commun (Camb); 2019 Jan; 55(8):1164-1167. PubMed ID: 30632564
[TBL] [Abstract][Full Text] [Related]
2. Catechol polymers for pH-responsive, targeted drug delivery to cancer cells.
Su J; Chen F; Cryns VL; Messersmith PB
J Am Chem Soc; 2011 Aug; 133(31):11850-3. PubMed ID: 21751810
[TBL] [Abstract][Full Text] [Related]
3. Acid-labile boronate-bridged dextran-bortezomib conjugate with up-regulated hypoxic tumor suppression.
Xu W; Ding J; Li L; Xiao C; Zhuang X; Chen X
Chem Commun (Camb); 2015 Apr; 51(31):6812-5. PubMed ID: 25787235
[TBL] [Abstract][Full Text] [Related]
4. Tumor extracellular acidity activated "off-on" release of bortezomib from a biocompatible dendrimer.
Wang M; Wang Y; Hu K; Shao N; Cheng Y
Biomater Sci; 2015 Mar; 3(3):480-9. PubMed ID: 26222291
[TBL] [Abstract][Full Text] [Related]
5. Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
Li D; Su T; Ma L; Yin F; Xu W; Ding J; Li Z
Eur J Med Chem; 2020 Aug; 199():112367. PubMed ID: 32474350
[TBL] [Abstract][Full Text] [Related]
6. Modular Assembly of Reversible Multivalent Cancer-Cell-Targeting Drug Conjugates.
Santos FMF; Matos AI; Ventura AE; Gonçalves J; Veiros LF; Florindo HF; Gois PMP
Angew Chem Int Ed Engl; 2017 Aug; 56(32):9346-9350. PubMed ID: 28594469
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
[TBL] [Abstract][Full Text] [Related]
8. Boronic acid shell-crosslinked dextran-b-PLA micelles for acid-responsive drug delivery.
Zhao Z; Yao X; Zhang Z; Chen L; He C; Chen X
Macromol Biosci; 2014 Nov; 14(11):1609-18. PubMed ID: 25142134
[TBL] [Abstract][Full Text] [Related]
9. Folate-targeted pH-sensitive bortezomib conjugates for cancer treatment.
Liu Y; Dai Z; Wang J; Tu Y; Zhu L
Chem Commun (Camb); 2019 Apr; 55(29):4254-4257. PubMed ID: 30901007
[TBL] [Abstract][Full Text] [Related]
10. Near infrared light-responsive and injectable supramolecular hydrogels for on-demand drug delivery.
Wang X; Wang C; Zhang Q; Cheng Y
Chem Commun (Camb); 2016 Jan; 52(5):978-81. PubMed ID: 26588349
[TBL] [Abstract][Full Text] [Related]
11. pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy.
Zhou M; Wei W; Chen X; Xu X; Zhang X; Zhang X
Nanomedicine; 2019 Aug; 20():102008. PubMed ID: 31121311
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib-catechol conjugated prodrug micelles: combining bone targeting and aryl boronate-based pH-responsive drug release for cancer bone-metastasis therapy.
Zhu J; Huo Q; Xu M; Yang F; Li Y; Shi H; Niu Y; Liu Y
Nanoscale; 2018 Oct; 10(38):18387-18397. PubMed ID: 30256367
[TBL] [Abstract][Full Text] [Related]
13. Self-assembled vehicle construction via boronic acid coupling and host-guest interaction for serum-tolerant DNA transport and pH-responsive drug delivery.
Yang B; Jia H; Wang X; Chen S; Zhang X; Zhuo R; Feng J
Adv Healthc Mater; 2014 Apr; 3(4):596-608. PubMed ID: 23983152
[TBL] [Abstract][Full Text] [Related]
14. pH-responsive supramolecular vesicles based on water-soluble pillar[6]arene and ferrocene derivative for drug delivery.
Duan Q; Cao Y; Li Y; Hu X; Xiao T; Lin C; Pan Y; Wang L
J Am Chem Soc; 2013 Jul; 135(28):10542-9. PubMed ID: 23795864
[TBL] [Abstract][Full Text] [Related]
15. Redox Sensitive Shell and Core Crosslinked Hyaluronic Acid Nanocarriers for Tumor-Targeted Drug Delivery.
Zheng H; Yin L; Zhang X; Zhang H; Hu R; Yin Y; Qiu T; Xiong X; Wang Q
J Biomed Nanotechnol; 2016 Aug; 12(8):1641-53. PubMed ID: 29342343
[TBL] [Abstract][Full Text] [Related]
16. Boronate cross-linked ATP- and pH-responsive nanogels for intracellular delivery of anticancer drugs.
Zhang X; Achazi K; Haag R
Adv Healthc Mater; 2015 Mar; 4(4):585-92. PubMed ID: 25388994
[TBL] [Abstract][Full Text] [Related]
17. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
18. pH/sugar dual responsive core-cross-linked PIC micelles for enhanced intracellular protein delivery.
Ren J; Zhang Y; Zhang J; Gao H; Liu G; Ma R; An Y; Kong D; Shi L
Biomacromolecules; 2013 Oct; 14(10):3434-43. PubMed ID: 24063314
[TBL] [Abstract][Full Text] [Related]
19. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery.
Meng L; Huang W; Wang D; Huang X; Zhu X; Yan D
Biomacromolecules; 2013 Aug; 14(8):2601-10. PubMed ID: 23819825
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-functionalized half-generation of sectorial dendrimers for anticancer drug delivery and enhanced biocompatibility.
Du X; Yin S; Wang Y; Gu X; Wang G; Li J
Carbohydr Polym; 2018 Dec; 202():513-522. PubMed ID: 30287030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
